Shield Therapeutics shares surge as revenue up on prescription growth
(Alliance News) - Shield Therapeutics PLC shares jumped on Wednesday as its revenue soared in 2024 and it said it expects to be cash flow positive by the end of 2025. Read More
Price | 2.75p on 15-04-2025 | at 05:00:06
---|---|
Change | 0.00p 0% |
Buy | 0.00p |
Sell | 0.00p |
Buy / Sell STX Shares |
Last Trade: | Sell 3,799.00 at 2.73p |
Day's Volume: | 0 |
Last Close: | 2.75p |
Open: | 0.00p |
ISIN: | GB00BYV81293 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 1.075p - 5.80p |
Market Capitalisation: | £29m |
VWAP: | 0.00p |
Shares in Issue: | 1,042m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 3,799 | 2.73p | Ordinary |
15:59:00 - 14-Apr-25 |
Sell* | 150,000 | 2.725p | Ordinary |
14:53:58 - 14-Apr-25 |
Sell* | 100,000 | 2.72p | Ordinary |
13:31:15 - 14-Apr-25 |
Buy* | 71,526 | 2.785p | Ordinary |
13:23:58 - 14-Apr-25 |
Buy* | 38,888 | 2.785p | Ordinary |
13:23:41 - 14-Apr-25 |
Sell* | 1,851 | 2.70p | SI Trade |
13:19:16 - 14-Apr-25 |
Buy* | 182 | 2.80p | SI Trade |
13:19:16 - 14-Apr-25 |
Buy* | 200,000 | 2.79p | Ordinary |
13:19:00 - 14-Apr-25 |
Buy* | 6,000 | 2.79p | Ordinary |
13:16:58 - 14-Apr-25 |
Sell* | 27,415 | 2.65p | Ordinary |
12:59:24 - 14-Apr-25 |
Shield Thera (STX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
11th Mar 2025 7:00 am | RNS | ACCRUFeR® launched in Canada |
13th Feb 2025 4:15 pm | RNS | PDMR Transaction Notification |
13th Feb 2025 7:00 am | RNS | Grant of Share Options |
5th Feb 2025 7:00 am | RNS | Unaudited full year trading update |
27th Jan 2025 7:00 am | RNS | Anders Lundstrom appointed CEO |
24th Dec 2024 11:25 am | RNS | Result of General Meeting & Total Voting Rights |
23rd Dec 2024 7:00 am | RNS | Results of RetailBook Offer |
6th Dec 2024 11:31 am | RNS | RetailBook Offer |
6th Dec 2024 11:30 am | RNS | Subscription by AOP Health to raise US$10 million |
21st Nov 2024 7:00 am | RNS | Business Update |